Early research (Phase 1)Looking for participantsNCT07159126What this trial is testingDS3610a in Participants With Advanced Solid TumorWho this might be right forSolid TumorsMetastatic Solid Tumors Daiichi Sankyo 70
Not applicableStudy completedNCT01987726What this trial is testingComprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsWho this might be right forRecurrent Breast CancerRecurrent Colon CancerRecurrent Rectal Cancer+5 more Ohio State University Comprehensive Cancer Center 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07367178What this trial is testingStudy of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast CancerWho this might be right forBreast CancerAdvanced HR+/HER2- Breast CancerAdvanced Triple-Negative Breast Cancer MedSIR 30
Large-scale testing (Phase 3)Looking for participantsNCT05760378What this trial is testingFamitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.Who this might be right forTriple-Negative Breast Cancer Fudan University 223
Early research (Phase 1)Study completedNCT03150810What this trial is testingStudy to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors BeiGene 139
Testing effectiveness (Phase 2)Study completedNCT00630110What this trial is testingPhase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forCancer Nereus Pharmaceuticals, Inc. 172
Large-scale testing (Phase 3)UnknownNCT06031597What this trial is testingRadiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyWho this might be right forNon-small Cell Lung Cancer Stage III Zhejiang Cancer Hospital 105
Early research (Phase 1)UnknownNCT03844438What this trial is testingA Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Luye Pharma Group Ltd. 30
Early research (Phase 1)Active Not RecruitingNCT06328738What this trial is testingELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast CancerWho this might be right forHER2-positive Breast CancerHER2-positive Gastric CancerHER2 Positive Solid Tumors+2 more Enliven Therapeutics 275
Early research (Phase 1)Looking for participantsNCT06487455What this trial is testingA Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumor Shanghai Pharmaceuticals Holding Co., Ltd 170
Testing effectiveness (Phase 2)Study completedNCT00135135What this trial is testingTherapy for Children With NeuroblastomaWho this might be right forNeuroblastoma St. Jude Children's Research Hospital 23
Early research (Phase 1)Study completedNCT03085225What this trial is testingTrabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.Who this might be right forOvarian CarcinomaSoft Tissue Sarcoma Institut Bergonié 40
Early research (Phase 1)UnknownNCT05333276What this trial is testingClinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced CancersWho this might be right forAdvanced Cancers Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 7
Early research (Phase 1)Study completedNCT03332576What this trial is testingPhase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer ImmunoVaccine Technologies, Inc. (IMV Inc.) 37
Early research (Phase 1)WithdrawnNCT02569489What this trial is testingDose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast CancerWho this might be right forBreast Cancer HUYABIO International, LLC.
Post-approval studies (Phase 4)Ended earlyNCT00604968What this trial is testingPegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)Who this might be right forBreast Neoplasms Merck Sharp & Dohme LLC 25
Large-scale testing (Phase 3)Ended earlyNCT03326674What this trial is testingTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCWho this might be right forBreast Cancer Odonate Therapeutics, Inc. 685
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07497074What this trial is testingJSKN033 Combination Therapy in Subjects With Advanced Cervical CancerWho this might be right forCervical Cancer Jiangsu Alphamab Biopharmaceuticals Co., Ltd 78
Testing effectiveness (Phase 2)Study completedNCT00965718What this trial is testingEvaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic CancerWho this might be right forPancreatic Cancer GC Cell Corporation 20
Early research (Phase 1)Study completedNCT00532090What this trial is testingA Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.Who this might be right forNeoplasms Hoffmann-La Roche 110